A Prospective Cohort Study of IgG4RD in China

Status Recruiting

Clinical Trial Summary

This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.

Clinical Trial Description

Immunoglobulin G4-related disease (IgG4-RD) is a recently defined emerging clinical entity characterized by tissue infiltration by IgG4-positive plasma cells, tissue fibrosclerosis and elevated serum IgG4 concentration.

In this study, patients with IgG4-RD will be investigated, including clinical presentation, laboratory findings and imaging study. All patients will be treated by standard care and follow-uped for at least 6 months. ;

Study Design

Related Conditions & MeSH terms

IgG4-related Disease

Clinical Trial Details

NCT number	NCT01670695
Study type	Observational
Source	Peking Union Medical College Hospital
Contact	Hua Chen, MD
Phone	86-10-69158797
Email	chen77hua@gmail.com
Status	Recruiting
Phase	N/A
Start date	January 2012
Completion date	January 2032

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03368274` - To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom	Phase 4
Not yet recruiting	`NCT03267875` - A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood	N/A
Completed	`NCT02616705` - Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
Completed	`NCT03669861` - Safety and Efficacy of Abatacept in IgG4-Related Disease	Phase 2
Recruiting	`NCT05625581` - Tofatib Treatment for IgG4-related Disease
Recruiting	`NCT04125511` - Characterizing IgG4-RD With 68Ga-FAPI PET/CT	Early Phase 1
Not yet recruiting	`NCT06285539` - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases	Phase 2
Not yet recruiting	`NCT05746689` - Study of Sirolimus in IgG4-related Disease	N/A
Completed	`NCT03690908` - Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic Disease
Completed	`NCT02899039` - Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease	N/A
Recruiting	`NCT04660565` - Belimumab Treatment for IgG4-related Disease	Phase 4
Recruiting	`NCT03023371` - National Registry of IgG4-RD in China	N/A
Unknown status	`NCT01758393` - Glucocorticoids in Patients With IgG4-RD	Phase 2/Phase 3
Completed	`NCT02705638` - Treatment of IgG4-Related Disease With Revlimid and Rituximab	Phase 1
Recruiting	`NCT03473912` - Meir Medical Center Rheumatologic Biobank
Not yet recruiting	`NCT03466970` - Plasmablast Detection From IgG4-Related Disease Patients	N/A